Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Cold Plasma for the Reduction of Lymphoceles Following PLND

NCT02658851 · Apyx Medical · Updated 2 Dec 2020

What is being tested
J-Plasma
For
Lymphoceles Following Pelvic Lymph Node Dissection
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 100 people. The full rules are on the registry page.
Where
United States
When
Starts or started June 2016, ends 27 June 2017. Registered 20 Jan 2016.
Results
Posted on the registry on 2 Dec 2020.

In the researchers' words

This study protocol will evaluate the efficacy of Bovie Medical's J-Plasma® helium based plasma technology in the reduction of lymphoceles following pelvic lymph node dissection (PLND) during robotic assisted radical prostatectomy (RARP). The J-Plasma® handpiece will be used during the PLND by dissecting the lymph nodes and sealing the lymphatic channels to prevent lymph leakage.
ClinicalTrials.gov, NCT02658851

Sites

  • Florida Hospital Global Robotics InstituteCelebration, Florida, United States